Cosciens Biopharma Inc's Customers Performance

Name: Cosciens Biopharma Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

CSCI

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


CSCI's Source of Revenues		During the corresponding time, Cosciens Biopharma Inc saw a revenue deteriorated by -46.84 % year on year, sequentially revenue grew by 19.08 %. While revenue at the Cosciens Biopharma Inc 's corporate clients • List of CSCI Customers

for the same period Cosciens Biopharma Inc revnue deteriorated by -46.84 % year on year, sequentially revenue grew by 19.08 %.

• List of CSCI Customers

Cosciens Biopharma Inc's Business Units


United states	61.4 %	of total Revenue
Germany	31.72 %	of total Revenue
United kingdom	6.09 %	of total Revenue
Other	0.79 %	of total Revenue
Active ingredients	93.85 %	of total Revenue
Active ingredients United states	61.4 %	of total Revenue
Active ingredients Germany	31.72 %	of total Revenue
Active ingredients Other	0.73 %	of total Revenue
Biopharmaceutical	6.15 %	of total Revenue
Biopharmaceutical United kingdom	6.09 %	of total Revenue
Biopharmaceutical Other	0.05 %	of total Revenue
Single customer	84.05 %	of total Revenue
Active ingredient	93.85 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Cosciens Biopharma Inc's Comment on Sales, Marketing and Customers

The company provides oat-based pipeline products, including oat-beta glucan, avenanthramides, and beta glucan derived from yeast, to customers and distribution partners. Symrise AG is a noted customer whose demand fluctuations affect the company's oat-based product offerings. The company focuses on markets related to oat-based products, encompassing commercialization, marketing, and product launch activities.

Cosciens Biopharma Inc’s Comment on Sales, Marketing and Customers

CSCI's Stock Performance relative to it's Customers

CSCI's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Cosciens Biopharma Inc	8.61	7.50	-10.36	28
SUBTOTAL	0.00	0.00	0.00	-

Sources: Cosciens Biopharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Cosciens Biopharma Inc’s corporate clients.
For your research, we’ve provided 9 tables on Cosciens Biopharma Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.